(Q42166140)

17 October 2017

Simvastatin-fluconazole causing rhabdomyolysis (English)

1 reference

17 October 2017

Aasma Shaukat

1

1 reference

17 October 2017

Mustafa Benekli

2

1 reference

17 October 2017

Georgirene D Vladutiu

3

1 reference

17 October 2017

James L Slack

4

1 reference

17 October 2017

Meir Wetzler

5

1 reference

17 October 2017

Maria R Baer

6

1 reference

17 October 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Annals of Pharmacotherapy

17 October 2017

1 reference

17 October 2017

37

1 reference

17 October 2017

1032-1035

1 reference

17 October 2017

7-8

1 reference

Drug treatment of lipid disorders

17 October 2017

1 reference

Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences

21 January 2018

1 reference

Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase

21 January 2018

1 reference

Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors

21 January 2018

1 reference

Effects of the antifungal agents on oxidative drug metabolism: clinical relevance

21 January 2018

1 reference

Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.

21 January 2018

1 reference

Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin

21 January 2018

1 reference

Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin

21 January 2018

1 reference

A method for estimating the probability of adverse drug reactions

21 January 2018

1 reference

Rhabdomyolysis and Renal Failure in Hypothyroidism

21 January 2018

1 reference

Hypothyroid myopathy with a strikingly elevated serum creatine kinase level

21 January 2018

1 reference

Statin-fibrate combination therapy

21 January 2018

1 reference

Myxoedema revealed by simvastatin induced myopathy

21 January 2018

1 reference

FDA adverse event reports on statin-associated rhabdomyolysis

21 January 2018

1 reference

The cholesterol lowering drug lovastatin induces cell death in myeloma plasma cells

21 January 2018

1 reference

Lovastatin induces a pronounced differentiation response in acute myeloid leukemias

21 January 2018

1 reference

Clinically relevant differences between the statins: implications for therapeutic selection

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1C467

1 reference

17 October 2017

1 reference